Biopharma Plastics Market [2028] Analysis bu Trends, Share, Demands, Forecast

Report Description

Biopharma Plastics Market is anticipated to expand significantly through 2028 due to the growing demand from the healthcare sector. In 2020, India's healthcare sector was worth about USD 280 billion.

Due to their features, such as low chemical reactivity, thermal stability, and high resistivity, biopharma plastics are widely used in the production of several healthcare products, including protective clothing, containers, syringes, disposable connections, and bioreactor bags. Moreover, factors including rising global healthcare costs and an increase in the number of cancer cases worldwide, therefore surges the demand of singe use plastic in the production of containers, syringes, and others, leading to growth of Global Biopharma Plastics Market in the projected period.

Ongoing Technological Advancement in Healthcare

Systems for controlled release and targeted delivery of medicinal drugs using nanoparticles are known as nano drug delivery systems. These are the brand-new yet emerging technologies for treating microbiological, cardiovascular, inflammatory, autoimmune, and cancerous disorders. Due to the site-specific and target-oriented medication delivery capabilities of nanotechnology, treating chronic illnesses like cardiovascular diseases (CVDs) is made much easier. Special type of packaging kits is manufactured in the prevention of these drugs from environment.

For instance, according to the ETHealthWorld, Nanotechnology is poised to shape the future of healthcare and The space where nanotechnology meets healthcare is called nanomedicine.

Therefore, increase in healthcare facilities and advancement in technology anticipate the market growth in the upcoming years.

Syringe Applicability Dominate the Market

For injecting & withdrawing liquid from the body, syringes are a prominent healthcare product. Increase in demand for prefilled syringes is due to their ease of use, low cost, minimum microbiological contamination, low injection mistakes, and low dilution errors. Pre-filled syringes reduce the number of steps for injection, offer higher dose accuracy and lower the risk of injury and cross-contamination.

Moreover, Pre-filled syringes are now a commonplace component of the medication life cycle and are frequently taken into consideration as early as Phase II of the drug development process.

For Instance, according to Drug Development & Delivery, Prefilled syringes and autoinjectors are manufactured focusing on the needs of the patient by providing a variety of parenteral medication quantities and allowing variable dosing regimens.

Thus, increasing focus for prefilled syringes lead to the growth of Global Biopharma Plastic Market in the forecast period.

Polyvinyl chloride (PVC) will be the Key Polymer Type

The versatility of polyvinyl chloride in the market is due to its capacity to withstand a variety of operations without breaking or cracking. It is ideal for creating syringes, disposable connections, depth filters, and other biopharma plastic products since it is flexible, UV and chemical resistant, and can readily manage high temperatures. Along with having outstanding mechanical properties, they have oxidation resistance capacity, water repellency with simultaneous vapor permeability, and water-repellency. As a result, the product is long-lasting, sustainable, and cost-effective, which has increased the use of biopharma plastics in protective wear in the healthcare sector.

For instance, in 2021, according to MPN, PVC is the most used polymer for single-use medical devices such as bags, tubing, masks and other disposal devices.

In addition, polytetrafluoroethylene and polyethylene are used in various applications due to their properties such as durability, gloss, and detergent resistance.

Therefore, the aforementioned factors are likely to boost market growth over the forecast period.

Recent Developments

In November 2022, Avantor Inc. opened New Distribution Center in Dublin, Ireland to support Biopharma market.
Solvay signed a MOUs with French start-up Ostiumin, to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced in November 2022.
In September 2022, Hanwha Solutions Corporation start using the LyondellBasell Lupotech T high-pressure polyethylene technology in Yeosu, South Korea.
DuPont Liveo, a healthcare solutions manufacturing facility started at the Cooper River Site in South Carolina opened by DuPont in July 2022.

Download Free Sample Report

Market Segmentation

Global Biopharma Plastics Market is segmented based on polymer type, application, and region. Based on the polymer type, the market is fragmented into polyvinyl chloride (PVC), polyethylene terephthalate (PET), polypropylene (PP), and others. Based on the application, the market is segmented into protective wear, containers, bioreactor bags, syringes, and others. Based on region, the market is divided into North America, Europe, Asia Pacific, South America, Middle East & Africa, By Company.

Market Players

BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont de Nemours, Inc., Tekni-Plex, Inc., Solvay S.A., Avantor, Inc., Bormioli Pharma S.p.A., Saudi Basic Industries Corporation are some of the key players of Global Biopharma Plastics Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Polymer Type Application
Regional scope	North America, Europe, Asia Pacific, South America, Middle East & Africa
Country scope	United States, Mexico, Canada, France, Germany, United Kingdom, Spain, Italy, China, India, South Korea, Japan, Indonesia, Brazil, Argentina, South Africa, Saudi Arabia, UAE
Key companies profiled	BASF SE, Spectrum Plastics Group, Celanese Corporation, LyondellBasell Industries Holdings B.V., DuPont de Nemours, Inc., Tekni-Plex, Inc., Solvay S.A., Avantor, Inc., Bormioli Pharma S.p.A., Saudi Basic Industries Corporation
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Biopharma Plastics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Biopharma Plastics Market, By Polymer Type:

Polyvinyl Chloride (PVC)
Polyethylene Terephthalate (PET)
Polypropylene (PP)
Others

Biopharma Plastics Market, By Application:

Protective Wear
Containers
Bioreactor Bags
Syringes
Others

Biopharma Plastics Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Spain
Italy

Asia-Pacific

China
India
South Korea
Japan
Indonesia

South America

Brazil
Argentina

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in Global Biopharma Plastics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Biopharma Plastics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biopharma Plastics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value & Volume

5.2. Market Share & Forecast

5.2.1. By Polymer Type (Polyvinyl Chloride (PVC), Polyethylene Terephthalate (PET), Polypropylene (PP), Others)

5.2.2. By Application (Protective Wear, Containers, Bioreactor Bags, Syringes, Others)

5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.4. By Company (2022)

5.3. Market Map

5.3.1. By Polymer Type

5.3.2. By Application

5.3.3. By Region

6. North America Biopharma Plastics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value & Volume

6.2. Market Share & Forecast

6.2.1. By Polymer Type

6.2.2. By Application

6.2.3. By Country

6.3. Pricing Analysis

6.4. North America: Country Analysis

6.4.1. United States Biopharma Plastics Market Outlook

6.4.1.1. Market Size & Forecast

6.4.1.1.1. By Value & Volume

6.4.1.2. Market Share & Forecast

6.4.1.2.1. By Polymer Type

6.4.1.2.2. By Application

6.4.2. Mexico Biopharma Plastics Market Outlook

6.4.2.1. Market Size & Forecast

6.4.2.1.1. By Value & Volume

6.4.2.2. Market Share & Forecast

6.4.2.2.1. By Polymer Type

6.4.2.2.2. By Application

6.4.3. Canada Biopharma Plastics Market Outlook

6.4.3.1. Market Size & Forecast

6.4.3.1.1. By Value & Volume

6.4.3.2. Market Share & Forecast

6.4.3.2.1. By Polymer Type

6.4.3.2.2. By Application

7. Europe Biopharma Plastics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value & Volume

7.2. Market Share & Forecast

7.2.1. By Polymer Type

7.2.2. By Application

7.2.3. By Country

7.3. Pricing Analysis

7.4. Europe: Country Analysis

7.4.1. France Biopharma Plastics Market Outlook

7.4.1.1. Market Size & Forecast

7.4.1.1.1. By Value & Volume

7.4.1.2. Market Share & Forecast

7.4.1.2.1. By Polymer Type

7.4.1.2.2. By Application

7.4.2. Germany Biopharma Plastics Market Outlook

7.4.2.1. Market Size & Forecast

7.4.2.1.1. By Value & Volume

7.4.2.2. Market Share & Forecast

7.4.2.2.1. By Polymer Type

7.4.2.2.2. By Application

7.4.3. United Kingdom Biopharma Plastics Market Outlook

7.4.3.1. Market Size & Forecast

7.4.3.1.1. By Value & Volume

7.4.3.2. Market Share & Forecast

7.4.3.2.1. By Polymer Type

7.4.3.2.2. By Application

7.4.4. Spain Biopharma Plastics Market Outlook

7.4.4.1. Market Size & Forecast

7.4.4.1.1. By Value & Volume

7.4.4.2. Market Share & Forecast

7.4.4.2.1. By Polymer Type

7.4.4.2.2. By Application

7.4.5. Italy Biopharma Plastics Market Outlook

7.4.5.1. Market Size & Forecast

7.4.5.1.1. By Value & Volume

7.4.5.2. Market Share & Forecast

7.4.5.2.1. By Polymer Type

7.4.5.2.2. By Application

8. Asia-Pacific Biopharma Plastics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value & Volume

8.2. Market Share & Forecast

8.2.1. By Polymer Type

8.2.2. By Application

8.2.3. By Country

8.3. Pricing Analysis

8.4. Asia-Pacific: Country Analysis

8.4.1. China Biopharma Plastics Market Outlook

8.4.1.1. Market Size & Forecast

8.4.1.1.1. By Value & Volume

8.4.1.2. Market Share & Forecast

8.4.1.2.1. By Polymer Type

8.4.1.2.2. By Application

8.4.2. India Biopharma Plastics Market Outlook

8.4.2.1. Market Size & Forecast

8.4.2.1.1. By Value & Volume

8.4.2.2. Market Share & Forecast

8.4.2.2.1. By Polymer Type

8.4.2.2.2. By Application

8.4.3. South Korea Biopharma Plastics Market Outlook

8.4.3.1. Market Size & Forecast

8.4.3.1.1. By Value & Volume

8.4.3.2. Market Share & Forecast

8.4.3.2.1. By Polymer Type

8.4.3.2.2. By Application

8.4.4. Japan Biopharma Plastics Market Outlook

8.4.4.1. Market Size & Forecast

8.4.4.1.1. By Value & Volume

8.4.4.2. Market Share & Forecast

8.4.4.2.1. By Polymer Type

8.4.4.2.2. By Application

8.4.5. Indonesia Biopharma Plastics Market Outlook

8.4.5.1. Market Size & Forecast

8.4.5.1.1. By Value & Volume

8.4.5.2. Market Share & Forecast

8.4.5.2.1. By Polymer Type

8.4.5.2.2. By Application

9. South America Biopharma Plastics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value & Volume

9.2. Market Share & Forecast

9.2.1. By Polymer Type

9.2.2. By Application

9.2.3. By Country

9.3. Pricing Analysis

9.4. South America: Country Analysis

9.4.1. Brazil Biopharma Plastics Market Outlook

9.4.1.1. Market Size & Forecast

9.4.1.1.1. By Value & Volume

9.4.1.2. Market Share & Forecast

9.4.1.2.1. By Polymer Type

9.4.1.2.2. By Application

9.4.2. Argentina Biopharma Plastics Market Outlook

9.4.2.1. Market Size & Forecast

9.4.2.1.1. By Value & Volume

9.4.2.2. Market Share & Forecast

9.4.2.2.1. By Polymer Type

9.4.2.2.2. By Application

10. Middle East and Africa Biopharma Plastics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value & Volume

10.2. Market Share & Forecast

10.2.1. By Polymer Type

10.2.2. By Application

10.2.3. By Country

10.3. Pricing Analysis

10.4. MEA: Country Analysis

10.4.1. South Africa Biopharma Plastics Market Outlook

10.4.1.1. Market Size & Forecast

10.4.1.1.1. By Value & Volume

10.4.1.2. Market Share & Forecast

10.4.1.2.1. By Polymer Type

10.4.1.2.2. By Application

10.4.2. Saudi Arabia Biopharma Plastics Market Outlook

10.4.2.1. Market Size & Forecast

10.4.2.1.1. By Value & Volume

10.4.2.2. Market Share & Forecast

10.4.2.2.1. By Polymer Type

10.4.2.2.2. By Application

10.4.3. UAE Biopharma Plastics Market Outlook

10.4.3.1. Market Size & Forecast

10.4.3.1.1. By Value & Volume

10.4.3.2. Market Share & Forecast

10.4.3.2.1. By Polymer Type

10.4.3.2.2. By Application

11. Market Dynamics

11.1. Drivers

11.1.1. Increase in healthcare expenditure

11.1.2. Rising cases of cancerous patients

11.1.3. Technological advancement in healthcare

11.2. Challenges

11.2.1. Fluctuation in Raw Material prices

11.2.2. Stringent Government regulations

12. Market Trends & Developments

12.1. Product Launches

12.2. Mergers & Acquisitions

12.3. Technological Advancements

13. Global Biopharma Plastics Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Types

15. Competitive Landscape

15.1. Business Overview

15.2. Type Offerings

15.3. Recent Developments

15.4. Financials (In Case of Listed Companies)

15.5. Key Personnel

15.6. SWOT Analysis

15.6.1. BASF SE

15.6.2. Spectrum Plastics Group

15.6.3. Celanese Corporation

15.6.4. LyondellBasell Industries Holdings B.V.

15.6.5. DuPont de Nemours, Inc.

15.6.6. Tekni-Plex, Inc.

15.6.7. Solvay S.A.

15.6.8. Avantor, Inc.

15.6.9. Bormioli Pharma S.p.A.

15.6.10. Saudi Basic Industries Corporation

16. Strategic Recommendations

Report Description

Table of content

Figures and Tables

Frequently asked questions

What are the key factors driving the Global Biopharma Plastics Market?

Who are the top players operating in Global Biopharma Plastics Market?

Which region is expected to account for the largest Global Biopharma Plastics Market share?

Which factors are hampering the growth of Global Biopharma Plastics Market?

Related Reports

Buy Now

Report Description

Table of content

Figures and Tables

Frequently asked questions

What are the key factors driving the Global Biopharma Plastics Market?

Who are the top players operating in Global Biopharma Plastics Market?

Which region is expected to account for the largest Global Biopharma Plastics Market share?

Which factors are hampering the growth of Global Biopharma Plastics Market?

Related Reports